Circulating Biomarkers for Immunotherapy Resistance in Liver Cancer
What is the Purpose of this Study?
- Provide samples of blood, stool, and tumor tissue
- Have your progress tracked by the study team.
You may also be asked to undergo a tumor biopsy.
Who Can Participate in this Study?
Adults with hepatocellular carcinoma (liver cancer) who will begin treatment with an immune checkpoint inhibitor.
What is Involved?
We are doing this study to track changes in the make-up of your tumor that occur during your treatment.